Improved osteosarcoma survival with addition of mifamurtide to conventional chemotherapy – Observational prospective single institution analysis

Improved osteosarcoma survival with addition of mifamurtide to conventional chemotherapy – Observational prospective single institution analysis

Purpose: Conventional osteosarcoma is an orphan disease. Current treatment approaches include combining a three drug chemotherapy schedule and surgery. The 3- and 5-year event-free survival (EFS) in localized disease is roughly 65 and 60%, respectively. The registration study of mifamurtide reported...

Full description

Bibliographic Details
Main Authors: Peter Múdry, Michal Kýr, Ondřej Rohleder, Michal Mahdal, Iva Staniczková Zambo, Marta Ježová, Tomáš Tomáš, Jaroslav Štěrba
Format: Article
Language:English
Published: Elsevier 2021-06-01
Series:Journal of Bone Oncology
Subjects:
Osteosarcoma
Mifamurtide
Survival
Single institution analysis
Comparative analysis
Online Access:http://www.sciencedirect.com/science/article/pii/S2212137421000166

Internet

http://www.sciencedirect.com/science/article/pii/S2212137421000166

Similar Items